Molecular Testing for Colon Cancer Falls Far Short of the Guidelines
Switching off DNA repair—how colorectal cancer evades targeted therapies through adaptive mutability | Signal Transduction and Targeted Therapy
Genetics of rectal cancer and novel therapies: primer for radiologists | SpringerLink
Should mismatch repair status be determined in all stage II and III colon cancer patients? | Colorectal Cancer
Association of mismatch repair status with survival and response to neoadjuvant chemo(radio)therapy in rectal cancer | npj Precision Oncology
Molecular and prognostic heterogeneity of microsatellite-unstable colorectal cancer
Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer | NEJM
Prognostic and predictive role of DNA mismatch repair status in stage II‐III colorectal cancer: A systematic review and meta‐analysis - Deng - 2020 - Clinical Genetics - Wiley Online Library
Colon Cancer and Lynch Syndrome | ARUP Laboratories
Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers | Nature Medicine
Genetics of Colorectal Cancer (PDQ®)–Health Professional Version - NCI
Immunohistochemical Tumor Testing For MMR Proteins: Image Details - NCI Visuals Online
Introduction to Molecular Pathways & Routine DNA MMR Deficiency Testing in Colorectal Adenocarcinoma
PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer | NEJM
Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms | British Journal of Cancer
Frontiers | MLH1 Deficiency Down-Regulates TLR4 Expression in Sporadic Colorectal Cancer
The diverse molecular profiles of lynch syndrome-associated colorectal cancers are (highly) dependent on underlying germline mismatch repair mutations - ScienceDirect
Immune Checkpoint Blockade Therapy in Patients With Colorectal Cancer Harboring Microsatellite Instability/Mismatch Repair Deficiency in 2022 | American Society of Clinical Oncology Educational Book
Microsatellite instability is central in colorectal cancer... | Download Scientific Diagram
Should mismatch repair status be determined in all stage II and III colon cancer patients? | Colorectal Cancer
Biomedicines | Free Full-Text | Identifying Novel Actionable Targets in Colon Cancer
How and When to Consider Genetic Testing for Colon Cancer? - Gastroenterology
Microsatellite Stability - MSS Biomarker | Colorectal Cancer Alliance
